Increased incidence of Gynae-oncological cancer is observed specifically in women above 50 years of age. Sarcopenia (a progressive and generalized loss of skeletal muscle mass, quality, and strength) is considered a reliable indicator of frailty, a poor prognostic factor in these patients. Various frailty scores and measurement of psoas muscle mass are time consuming, can't be done in patients unable to walk and altered mental status. The investigators wanted to evaluate if bedside ultrasound guided skeletal muscle measurement, as a measure of sarcopenia, can be used to predict post operative length of stay.
All consecutive consenting patients above 50 years of age, having a Charlson Comorbidity Index score of 3 or more, undergoing open surgeries for GCs.
None
All patients above 50 years of age, with Charlson Comorbidity Index Score of 3 or more, presenting to the gynaecological oncology OPD with Gynacological Cancer to be treated with open surgery.
Cohort
Prospective
Bed Side ultrasound guided muscle mass estimation of lower extremity
Procedure/SurgeryBed Side ultrasound guided muscle mass estimation of psoas major, rectus femoris, vastus intermedius and tibialis anterior.
Prolonged length of hospital stay
Length of hospital stay above 3rd Quartile at 9 days
Incidence of severe morbidity as classified by the Clavien Dindo Score.
Incidence of severe morbidity as classified by the Clavien Dindo Score.
Type of morbidity as defined by the Post Operative Morbidity Survey.
Type of morbidity as defined by the Post Operative Morbidity Survey.
30-day and 90-day readmission
Readmission within 30 day/ 90 days from the day of discharge
30-day and 90-day mortality.
Mortality within 30 day/ 90 days from the day of discharge
Click on the lead sponsor to view all of their trials.
